Redx Pharma Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 53

Employees

  • Latest Deal Type
  • PIPE
  • (In Progress)

  • Latest Deal Amount
  • $68M

  • Investors
  • 3

Redx Pharma General Information

Description

Fibrx Therapeutics Inc is a clinical-stage biotechnology company focused on the development of novel, small molecule, targeted medicines for fibrotic disease. The company's flagship program is RXC008, a GI-restricted pan-ROCK inhibitor for the treatment of fibrostenotic Crohn's disease. Its pipeline also includes zelasudil (RXC007), a next-generation selective ROCK2 inhibitor, and a pre-clinical Discoidin Domain Receptor (DDR) inhibitor program.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Block 33, Mereside
  • Alderley Park, Alderley Edge
  • Macclesfield SK10 4TG
  • England, United Kingdom
+44 01625
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Block 33, Mereside
  • Alderley Park, Alderley Edge
  • Macclesfield SK10 4TG
  • England, United Kingdom
+44 01625

Redx Pharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Redx Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
18. PIPE 14-Aug-2026 $68M In Progress Clinical Trials - Phase 2
17. Reverse Merger 14-Aug-2026 Announced Clinical Trials - Phase 2
16. Later Stage VC (Series A) 29-Aug-2026 Completed Clinical Trials - Phase 2
15. PIPE 18-Oct-2023 Completed Clinical Trials - Phase 1
14. PIPE 19-May-2022 Completed Clinical Trials - Phase 1
13. 2PO 21-Dec-2020 Completed Clinical Trials - Phase 1
12. Buyout/LBO 13-Mar-2020 Cancelled Clinical Trials - Phase 1
11. Bankruptcy: Admin/Reorg 24-May-2017 Completed Bankruptcy: Admin/Reorg
10. PIPE 08-Feb-2017 $18.5M $77M Completed Clinical Trials - Phase 1
9. PIPE 01-Apr-2016 $14.3M $58.6M Completed Clinical Trials - Phase 1
To view Redx Pharma’s complete valuation and funding history, request access »

Redx Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Fibrx Therapeutics Inc is a clinical-stage biotechnology company focused on the development of novel, small molecule, ta
Drug Discovery
Macclesfield, United Kingdom
53 As of 2025

Seattle, WA
 

Abingdon, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Redx Pharma Competitors (42)

One of Redx Pharma’s 42 competitors is Omeros, a Formerly VC-backed company based in Seattle, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Omeros Formerly VC-backed Seattle, WA
Immunocore Holdings Formerly VC-backed Abingdon, United Kingdom
Alector Formerly VC-backed South San Francisco, CA
Kyntra Bio Formerly VC-backed San Francisco, CA
Vertex Pharmaceuticals Formerly VC-backed Boston, MA
You’re viewing 5 of 42 competitors. Get the full list »

Redx Pharma Patents

Redx Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202500342-D0 Compounds Pending 10-Jan-2025
GB-202416725-D0 Compounds Inactive 13-Nov-2024
GB-202406330-D0 Compounds Inactive 07-May-2024
AU-2025233345-A1 Method of making kinase inhibitors Pending 05-Mar-2024
GB-202403179-D0 Method of making kinase inhibitors Inactive 05-Mar-2024 C07D307/33
To view Redx Pharma’s complete patent history, request access »

Redx Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Redx Pharma Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
The University of Liverpool University
Skye Bioscience Corporation Minority
Sofinnova Partners Venture Capital Minority
To view Redx Pharma’s complete investors history, request access »

Redx Pharma FAQs

  • When was Redx Pharma founded?

    Redx Pharma was founded in 2010.

  • Where is Redx Pharma headquartered?

    Redx Pharma is headquartered in Macclesfield, United Kingdom.

  • What is the size of Redx Pharma?

    Redx Pharma has 53 total employees.

  • What industry is Redx Pharma in?

    Redx Pharma’s primary industry is Drug Discovery.

  • Is Redx Pharma a private or public company?

    Redx Pharma is a Private company.

  • What is Redx Pharma’s current revenue?

    The current revenue for Redx Pharma is .

  • How much funding has Redx Pharma raised over time?

    Redx Pharma has raised $202M.

  • Who are Redx Pharma’s investors?

    The University of Liverpool, Skye Bioscience, and Sofinnova Partners have invested in Redx Pharma.

  • Who are Redx Pharma’s competitors?

    Omeros, Immunocore Holdings, Alector, Kyntra Bio, and Vertex Pharmaceuticals are some of the 42 competitors of Redx Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process